enterabio.com (ENTX) Company Long-Term Loans and Borrowings

Entera Bio - graphic logo of issuer ENTX

Entera Bio Ltd. (ENTX) develops innovative systems to transform injectable drugs into tablet forms, leveraging licensing agreements with global behemoths to ensure a stable cash flow. The company creates unique peptide and protein delivery methods in its Israeli laboratories. This price chart reflects the 0.00 indicator. Despite regional tensions, the business's medical profile protects the company from sanction risks.

ENTX Entera Bio Ltd: Company Long-Term Debts in the range 07/04/2022 - 10/28/2026

Financial and market metric breakdowns for Entera Bio (ENTX)

- price and consensus price forecast:
Stock Price Entera Bio Ltd|ENTX - Price Target Chart
- market capitalization data:
Market Value Entera Bio|ENTX - Total Company Value
- book capitalization data:
Accounting Value per Share Entera Bio|ENTX - Book Capitalization|Market Capitalization to Book Value Ratio enterabio.com|ENTX - Cumulative Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Entera Bio Ltd.|ENTX - Long-Term Debt to Equity|Current Liabilities to Capital Entera Bio Ltd|ENTX - Company Total Debt|Debt to Book Capital Entera Bio|ENTX - Company Long-Term Debts|Company Short-Term Loans and Borrowings Entera Bio
Fundamental company analysis:ENTX (Entera Bio Ltd.)
Manufactured products of enterabio.com

For Entera Bio Ltd. (ENTX), investment attractiveness is directly linked to the capital intensity of developing oral drug formulations, making the monitoring of debt load a critical survival factor. Statistics on the issuer's long-term liabilities capture the daily dynamics of the total debt, allowing investors to assess the risk of rising interest expenses and the company's level of financial stability amid a high demand for liquidity to fund clinical trials.

Analysis of competing companies

haleon.com - Company Long-Term Debts|Company Long-Term Debt Kenvue (KVUE)|VRNA: Company Long-Term Loans and Borrowings|MENS (Jyong Biotech Corp) - Company Long-Term Debt|Ligand Corp (LGND) - Company Long-Term Liabilities|AMRX (Amneal Pharmaceuticals) - Company Long-Term Debts|Company Long-Term Debts perrigo.com (PRGO)|Alvotech SA (ALVO) - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings LQDA (Liquidia Corp)|GLPG: Company Long-Term Debt|ANIP - Long-Term Debt|Company Long-Term Liabilities MannKind Corporation MNKD|AMPH - Amount of Long-Term Liabilities|Company Long-Term Debts Pacira BioSciences, Inc. PCRX|ARS Pharmaceuticals Inc (SPRY) - Company Long-Term Loans and Borrowings|Company Long-Term Debts TBPH (Theravance)|Long-Term Debt AQST|scPharmaceuticals Inc. (SCPH) - Company Long-Term Debt|Company Long-Term Loans and Borrowings tectonictx.com (TECX)|TNXP: Company Long-Term Debts|SXT Pharmaceuticals - Long-Term Debt|Eupraxia Pharma (EPRX) - Company Long-Term Debt|BioHarvest Sciences Inc (BHST) - Company Long-Term Indebtedness|EXOZ - Company Long-Term Liabilities|Oramed Pharmaceuticals Inc. (ORMP) - Amount of Long-Term Liabilities|Company Long-Term Debts HYFT (MindWalk Holdings Inc.)|Long-Term Debt ABVC|Cumberland Pharma (CPIX) - Company Long-Term Debt|Company Long-Term Loans and Borrowings Quantum BioPharma Corp (QNTM)|Company Long-Term Debts FGEN (FibroGen, Inc.)|TELO - Company Long-Term Debts|Company Long-Term Liabilities Rani Therapeutics Inc (RANI)|SNYR - Company Long-Term Loans and Borrowings|rallybio.com (RLYB) - Company Long-Term Debts|Lexaria Bioscience Corp. (LEXX) - Company Long-Term Debt|PULM: Company Long-Term Debts|Long-Term Debt Volume PTHL|Aptorum Group Limited - Company Long-Term Debt|Long-Term Debt Lyra Therapeutics Inc. LYRA|Company Long-Term Liabilities Impact BioMedical Inc|TNF Pharmaceuticals Inc. - Company Long-Term Loans and Borrowings|YCBD - Company Long-Term Debt|painreform.com (PRFX) - Company Long-Term Debt|CYTO - Company Long-Term Liabilities|Lipella Pharmaceuticals Inc (LIPO) - Amount of Long-Term Liabilities|Company Long-Term Debts Optinose (OPTN)|Company Long-Term Indebtedness Pieris Pharma (PIRS)|PROC (Procaps Group S.A.) - Company Long-Term Liabilities|Long-Term Debt Volume petrospharma.com (PTPI)|QLI: Company Long-Term Debts|Acelyrin Inc. - Long-Term Debt|TFF Pharma (TFFP) - Company Long-Term Debt